Lannett receives FDA approval for generic temozolomide capsules

Lannett Company’s subsidiary Kremers Urban Pharma has received FDA approval to produce generic temozolomide capsules. The capsules will be made in dosages of 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, and 250 mg. The capsules are the therapeutic equivalent to Temodar capsules produced by Merck.

Read the source article at